UPDATE 1-Pfizer's 2015 forecast disappoints, crimped by generics, dollar
January 27, 2015 at 07:51 AM EST
Jan 27 (Reuters) - Pfizer Inc reported stronger-than-expected quarterly sales due to cost cuts and demand for its vaccines and cancer drugs, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar.